Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.

Saved in:
Bibliographic Details
Title: Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.
Authors: Lin DS; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan., Lo HY; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan., Yang CW; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, No. 25, Lane 442, Section 1, Jingguo Rd, North District, Hsinchu City, 300, Taiwan. yang.chung.wei@gmail.com.; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. yang.chung.wei@gmail.com., Wu CC; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. chihchengwumd@gmail.com.; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, No. 25, Lane 442, Section 1, Jingguo Rd, North District, Hsinchu City, 300, Taiwan. chihchengwumd@gmail.com.; Institute of Biomedical Engineering, National Tsing-Hua University, Hsinchu, Taiwan. chihchengwumd@gmail.com.; Institute of Cellular and System Medicine, National Health Research Institute, Zhunan, Taiwan. chihchengwumd@gmail.com.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 83-96. Date of Electronic Publication: 2025 Aug 25.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-187X
DOI:10.1007/s40256-025-00760-x